Tradjenta Tablet, Film Coated
Product Images NDC 55154-0410

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tradjenta (NDC 55154-0410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Image 01)

Label for Tradjenta 5 mg film-coated tablets containing linagliptin. The label states the medication is Rx only and includes a dosage instruction to take one tablet daily. It mentions the quantity of approximately 2640 tablets and includes storage instructions. Distributed by Cardinal Health 107, LLC, with bulk manufacturer Boehringer Ingelheim Pharmaceuticals, Inc., made in Italy. The label includes barcodes and a warning to keep out of reach of children.*

FDA Label Image

Tradjenta 01

Chemical structure of linagliptin, the active ingredient in Tradjenta 5 mg oral film-coated tablets. The diagram shows the molecular framework with labeled atoms and bonds characteristic of this compound.*

FDA Label Image

Tradjenta 02

A line graph comparing the percentage of patients experiencing an event over time (up to 3.5 years) for two groups: Placebo and linagliptin. The y-axis shows patients with events (%) from 0 to 30%, and the x-axis shows years. Below the graph, a table lists the number of patients at risk for each group at various time points throughout the study.*

FDA Label Image

Tradjenta 03

A line graph comparing the percentage of patients with events over a 7-year period for linagliptin and glimepiride. The y-axis shows patients with events (%) and the x-axis shows years. Linagliptin is represented by a solid line and glimepiride by a dashed line. The graph includes patient counts at risk for both drugs at various time points below the x-axis.*

FDA Label Image

Tradjenta 04

Tradjenta 5 mg film-coated tablets packaging label. The label includes the product name Tradjenta, the active ingredient linagliptin, and the strength of 5 mg. The dosage form is oral film-coated tablets. The labeler is Cardinal Health 107, LLC, and the package includes a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.